The Market's Dominance in Cancer Treatment
The cancer segment, particularly brain metastases and malignant tumors, is a dominant force in the gamma knife market. Gamma Knife radiosurgery is an effective, non-invasive treatment option for a variety of brain cancers. It is particularly valuable for treating small, deep-seated tumors or those that have spread to multiple areas of the brain, as it can deliver a high dose of radiation to a precise target without damaging the surrounding critical structures.
The increasing incidence of cancer worldwide, coupled with the growing number of patients who develop brain metastases as a result of improved systemic cancer treatments, is creating a massive and growing patient population that can benefit from Gamma Knife therapy. As more healthcare professionals and patients become aware of its efficacy and safety, the demand for this technology in oncology is expected to continue its upward trajectory.